切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - RET - IMPDH - Voltage-gated Potassium (KV) Channels - JAK

31件产品中的 1-10

页面
每页
清除全部
  1. Cerdulatinib (PRT062070)
    B8023 Cerdulatinib (PRT062070)
    Target: JAK|Syk|TYK2
    Summary: Syk/JAK抑制剂
      ≥22.3 mg/mL
      insoluble in H2O
  2. Psora 4
    B7659 Psora 4
     1 Citation
    Target: Voltage-gated Potassium (KV) Channels
    Summary: Kv1.3阻断剂
      ≥15.75 mg/mL
      insoluble in H2O
  3. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    中文名: 富马酸伊布利特
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: III类抗心律失常药物
      ≥25.6 mg/mL
      ≥16.4 mg/mL
  4. GLPG0634
    B1130 GLPG0634
     1 Citation
    中文名: 菲戈替尼
    Target: JAK
    Summary: JAK1抑制剂
      ≥21.3 mg/mL
      insoluble in H2O
  5. Cisapride
    B1198 Cisapride
    Target: Voltage-gated Potassium (KV) Channels|5-HT4 Receptor
    Summary: 5-HT4受体激动剂
      ≥23.3 mg/mL
      insoluble in H2O
  6. Merimepodib
    B1112 Merimepodib
    Target: IMPDH
    Summary: IMPDH(肌苷单磷酸脱氢酶)的新型非竞争性抑制剂
      ≥45.2 mg/mL
      insoluble in H2O
  7. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  8. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    中文名: 乐伐替尼,仑伐替尼
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR抑制剂
      ≥21.35 mg/mL
      insoluble in H2O
  9. PP 1
    A8215 PP 1
    Target: Src|EGFR|JAK|ZAP-70
    Summary: Src家族酪氨酸激酶抑制剂
      ≥7.03 mg/mL
      insoluble in H2O
  10. Regorafenib
    A8236 Regorafenib
     4 Citation
    中文名: 瑞戈非尼
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
      ≥25.04 mg/mL
      insoluble in H2O

31件产品中的 1-10

页面
每页